Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
476.60    4.20 (0.89%)
Bid:
476.20
Ask:
476.60
Spread: 0.40 (0.084%)
Market Cap: £2.45b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Annual Financial Report

Today 11:05

RNS Number : 7756H
QinetiQ Group plc
10 June 2026
 

QINETIQ GROUP PLC

 

Availability of Annual Report and Accounts 2026

and Notice of 2026 Annual General Meeting

 

10 June 2026 - QinetiQ Group plc ('QinetiQ' or the 'Company') has today published the following documents:

· QinetiQ 2026 Annual Report and Accounts;

· Notice of 2026 Annual General Meeting;

· Notice of Availability: and

· Form of Proxy.

The documents are available to view or download from the Company's website at

· https://www.qinetiq.com/en/investors/results-reports-and-presentations

· https://www.qinetiq.com/en/investors/shareholder-services/agm

In compliance with UK Listing Rule 6.4.1R, copies of the above documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

These documents are today being posted or otherwise made available to shareholders.

The QinetiQ 2026 Annual General Meeting will be held at 11.00 am on Thursday 16 July 2026 at Ashurst LLP, London Fruit & Wool Exchange, 1 Duval Square, London E1 6PW.

The 2026 Annual Report should be read in conjunction with the Preliminary Results announcement issued on 21 May 2026, both of which can be viewed on the Company's website at https://www.qinetiq.com/en/investors. Together they constitute the material required by DTR 6.3.5R (1A) to be communicated to the media in unedited full text through a Regulatory Information Service. This material is not a substitute for reading the QinetiQ 2026 Annual Report in full.

 

About QinetiQ:

 

QinetiQ is a leading provider of mission-critical defence and security solutions to the UK and its allies, protecting lives by supporting national security priorities. We employ c.7,500 highly skilled people and our innovative research and development, specialist engineering expertise, unique test and training facilities and mission support and operations capabilities help deliver sustained warfighting readiness and operational advantage for customers around the world. Find out more at QinetiQ.com or follow us on LinkedIn and X @QinetiQ.

 

 

For further information please contact:

 

Andrew Carter, Group Investor Relations Director: +44 (0) 7392 289116

Stephanie Mann, Group Head of Media Relations: +44 (0) 7770 720268

James Field, Company Secretary: +44 (0) 7841 662957

 

 

LEI: 213800S8OBDOZMCMUW34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSFMMMTMTMBBTF
Date   Source Headline
10th Jun 202611:05 amRNSAnnual Financial Report
9th Jun 20265:00 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.